TY  - JOUR
AU  - Bazhenova, Lyudmila
AU  - Minchom, Anna
AU  - Viteri, Santiago
AU  - Bauml, Joshua M.
AU  - Ou, Sai-Hong Ignatius
AU  - Gadgeel, Shirish M.
AU  - Manuel Trigo, Jose
AU  - Backenroth, Daniel
AU  - Li, Tracy
AU  - Londhe, Anil
AU  - Mahadevia, Parthiv
AU  - Girard, Nicolas
PY  - 2021
DO  - 10.1016/j.lungcan.2021.10.020
SN  - 0169-5002
UR  - https://hdl.handle.net/10668/27958
T2  - Lung cancer
AB  - Introduction: Real-world clinical outcomes in patients with advanced NSCLC harboring EGFR exon 20 insertion (exon20ins) mutations have not been extensively studied. We conducted a retrospective cohort study to assess the clinical outcomes of EGFR...
LA  - en
PB  - Elsevier ireland ltd
KW  - Non-small cell lung cancer
KW  - Advanced lung cancer
KW  - EGFR mutations
KW  - EGFR exon 20 insertions
KW  - Flatiron registry
KW  - Cell lung-cancer
KW  - 1st-line treatment
KW  - Open-label
KW  - Carboplatin-paclitaxel
KW  - Phase-iii
KW  - Chemotherapy
KW  - Afatinib
KW  - Adenocarcinoma
KW  - Gefitinib
KW  - Survival
TI  - Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations
TY  - research article
VL  - 162
ER  -